Rep. Richard Dean McCormick (R-Ga.) has disclosed the sale of Illinois Tool Works Inc. (ITW) common stock in a Periodic Transaction Report filed under the STOCK Act. The transaction, executed by McCormick himself, was dated July 30, 2026, and was valued in the disclosed range of $1,001 to $15,000. The holding was sold out of a Growth Partners Roth IRA, one of the retirement accounts McCormick uses for reportable securities transactions.
The STOCK Act requires members of Congress to publicly report transactions in stocks, bonds, and other securities within 45 days of execution, a rule intended to give the public visibility into potential financial interests that could intersect with legislative work. Filing a report of this kind is a routine legal obligation and does not, on its own, indicate any wrongdoing or suggest that the lawmaker had access to nonpublic information.
A Notable Timing Overlap
What makes this particular filing worth flagging is its proximity to activity from inside Illinois Tool Works itself. Company insider Susan Crown also sold ITW shares, in a transaction dated August 7, 2026, valued at $17,206. That sale came within roughly a week of McCormick’s own disclosed transaction date, placing both moves inside the same 30-day window.
Overlapping sales by a member of Congress and a corporate insider in the same stock, close together in time, are the kind of pattern that whoisbuyingnow.com tracks because it can highlight where congressional trading activity and insider trading activity intersect. It is not evidence that the two transactions are connected, coordinated, or based on shared information. Lawmakers manage diversified portfolios, often through advisors or retirement vehicles like the Growth Partners Roth IRA used here, and insiders at large industrial companies like Illinois Tool Works routinely adjust their holdings for reasons unrelated to any single external event.
Illinois Tool Works is a diversified manufacturer with operations spanning automotive, food equipment, test and measurement, and specialty products, making it a fairly common holding across both institutional and individual portfolios, including those of members of Congress with broad index or blue-chip exposure.
This report is drawn directly from the disclosure filed with the U.S. House of Representatives and reflects only the transaction details made public in that filing. No additional information about the motivation behind the sale, McCormick’s broader portfolio strategy, or any relationship between his transaction and Crown’s insider sale has been disclosed. As with all STOCK Act filings, the record exists to inform the public, not to draw conclusions about intent.